Vir Biotechnology to Provide Pipeline Update at 38th Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, will present tomorrow, January 14th, at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco.

Click to view original post